Also, in line with what was observed in ovarian cancer [58], the expression of NICD was decreased in the USC cell line when Gal3 was knocked out or pharmacologically inhibited, suggesting that Gal3 may support stem-like properties through the same pathway. Here, LGALS3 is linked to ovarian cancer.